Welcome, please login:
[Login]   |  [Join]  |  [Renew]   |   [Contact Us]

Bioceramics 2014 Panelists

Register for Bioceramics 2014


James Adair

James H. Adair, chief science officer, Keystone Nano; professor, MSE, Bioengineering and Pharmacology, The Pennsylvania State University; associate director, Penn State Center on Nanomedicine and Materials


Panel: New Technologies Panel Discussion


Biography: Adair received his BS in Chemistry (1975) and his MS (1979) and PhD (1981) in Materials Science and Engineering, all from the University of Florida. From 1981-1982, he was a Fulbright Post-doctoral Fellow at the University of Western Australia in the Department of Soil Science and Plant Nutrition and the Royal Perth Hospital where he studied the biophysical chemistry origin of pathological biomineralization including human kidney stone disease. He was a Principal Research Scientist at Battelle Memorial Institute from 1982-1986. He joined Penn State as a Research Associate at the Materials Research Lab from 1986-1990. Adair was a faculty member from 1990 to 1997 at the University of Florida. Adair is the author or co-author of over 250 publications, thirteen patents, and several copyrights on computer software. He has been chair or co-chair of many symposia related to materials chemistry and colloid and powder processing science at ACerS and American Chemical Society national and international meetings. He is also the co-editor of tweleve books. Adair is a Fellow of the American Ceramic Society and the World Academy of Ceramics.


Orville Bailey

Orville Bailey, president and founder, Covalent Coating Technologies, LLC


Panel: New Technologies Panel Discussion


Biography: Bailey is a 20-year veteran in the materials and aerospace industry, most recently serving as Director of Manufacturing Quality for Pratt & Whitney. Bailey provided operations and engineering leadership for OEM and aftermarket coating operations while at Pratt & Whitney. He has also worked for General Electric and Galileo Electro-Optics (Corning). Bailey is a materials scientist and certified Shainin Red-X Master.


John Brunelle 

John Brunelle, chief technology officer, BioStructures LLC


Panel: Orthopedics II Panel Discussion


Biography: Brunelle joined BioStructures in April 2012 and has over 12 years of medical device development experience in the areas of sports medicine and orthobiologics. Prior to joining BioStructures, he held management positions at Synovis Orthopedics & Woundcare and Pegasus Biologics where he led the development of biologic-based systems for soft tissue repair. Brunelle started his career at Smith & Nephew Endoscopy developing osteoconductive impants and arthroscopic delivery systems. He holds degrees in mechanical and plastics engineering, as well as a doctorate degree in biomedical engineering from the University of Massachusetts.


Delbert Day

Delbert E. Day, Curators’ Professor Emeritus of Materials Science and Engineering and Senior Investigator of the Graduate Center for Materials Research, Missouri University of Science and Technology


Panel: Radiotherapeutics Panel Discussion


Biography: During his career, Day has published more than 390 technical papers, edited three books and been granted 61 US and foreign patents. His patents include glass microspheres for medical (radioembolization of malignant tumors) and dental applications, bioactive glasses for wound healing and bone repair, chemically durable iron phosphate glasses for vitrifying nuclear waste, optically transparent composites, and high temperature ceramics. He conducted the first US glass melting experiments in micro-gravity on NASA’s Space Shuttle and is co-inventor of special purpose glass microspheres, TheraSphereTM, which are now being used at more than 170 sites worldwide to treat patients with inoperable liver cancer. He is a co-inventor of “Glasphalt,” where waste glass is recycled as part of the aggregate in asphalt paving. His numerous honors and awards include election to the National Academy of Engineering, Distinguished Life Member (and past president) of ACerS, The Presidential Award for Research and Creativity and the Presidential Citation for Alumni Service Award, selection as the Nation’s Outstanding Young Ceramic Engineer (Pace Award) by the National Institute of Ceramic Engineers, the Hosler Alumni Scholar Medal for Scientific Achievement, and the Chancellor’s Medal and Doctor of Science, Honoris Causa.


David Dean 

David Dean, associate professor, college of medicine, The Ohio State University


Panel: Orthopedics I Panel Discussion


Biography: Dean is an Associate Professor of Plastic Surgery in the College of Medicine, and a member of the Center for Regenerative Medicine and Cell-Based Therapies, at The Ohio State University in Columbus, Ohio. He earned the PhD degree at the City University of New York (New York, NY) in 1993. He was a Postdoctoral Fellow in Plastic Surgery at New York University (New York, NY) before joining the faculty of the School of Medicine at Case Western Reserve University (CWRU) (Cleveland, OH) from 1994-2013. He directed the Imaging Laboratory of the CWRU Department of Neurological Surgery where he developed and patented methods for the Computer Aided Design (CAD) and additive manufacture (3D printing) of medical implants. He directs the Osteo Engineering Laboratory at The Ohio State University which focuses on craniofacial regenerative medicine. The Osteo Engineering Laboratory’s current research includes implant CAD, biomechanical modeling, and additive manufacturing, as well as the use of bone progenitor cells, growth factors, and bioreactor technologies for the production of bone tissue engineered implants.


David Greenspan 

David C. Greenspan, owner, Spinode Consulting


Panel: Bioceramic Testing Panel Discussion


Biography: Greenspan is currently owner of Spinode Consulting, a medical device consulting business. He has served as the vice president of product development for Tutogen Medical and RTI Biologics, chief technical officer and co-founder of NovaMin Technologies, the vice president of research and development and co-founder of USBiomaterials. He began his career with Howmedica, an orthopedic implant manufacturer. He is co-inventor of the NovaMin technology, along with numerous patents for application of bioactive glasses in medicine. His educational background includes a BS in Glass Science from Alfred University and a PhD in Materials Science from the University of Florida. He holds 35 US and International patents and has published and presented scientific papers, with over 40 peer-reviewed publications and more than 65 presentations at international conferences. He is a member of the ASTM F-4 Committee on Medical Devices, as well as a past member of ISO TC 194. He served as Chairman of the External Advisory Board for the Department of Materials Science and Engineering at Pennsylvania State University and is on the External Advisory Board of both Biomedical Engineering and Materials Science and Engineering at the University of Florida.


William David Hill 

William David Hill, associate professor, departments of cellular biology and anatomy, neurology, and orthopadic surgery, Georgia Regents University; Brain and Behavior Discovery Institute; and Institute for Regenerative and Reparative Medicine


Panel: Orthopedics II Panel Discussion


Biography: Dr. Hill is a biomedical research scientist at Georgia Regents University. His research focuses on the use of stem cells in addressing acute and chronic disease. This involves musculo-skeletal injury, including bone defects, orthopedic surgery and osteoporosis. He is targeting ways to modify stem cell niche sites both locally and systemically to improve endogenous stem cell populations and facilitate the engraftment and survival of transplanted stem cells. This includes novel delivery technologies with a current focus on ceramic microspheres. Hill is funded by NIH and the Veterans Administration, has over 69 peer-reviewed publications, serves on 3 editorial boards and is a reviewer for over 20 other journals, has served on numerous grant review panels and holds two patents. He received his PhD in Neurobiology and Anatomy from the Wake Forest University School of Medicine and did his Post-Doctoral fellowship in the Department of Laboratory Medicine and Pathology at the University of Pennsylvania.


Steve Jung 

Steve Jung, chief technology officer, Mo-Sci Corporation


Panel: Bioceramic Testing Panel Discussion 


Biography: Jung graduated from Missouri S&T with a PhD in Materials Science and Engineering in 2010. During his time, he studied bioactive glasses for hard and soft tissue regeneration. Previously, he was a senior research and development engineer at Mo-Sci Corporation, located in Rolla MO, developing glass and ceramic materials for tissue regeneration and other biological applications. 


Wayne Mullett

Wayne Mullett, director, development, TheraSphere, BTG International Canada Inc.


Panel: Radiotherapeutics Panel Discussion


Biography: Mullett has 15 years of experience in drug discovery/development and medical device commercial support. Dr. Mullett transitioned to BTG from Nordion, where he spent 5 years as the Director, Radiopharmaceutical Development, overseeing Nordion’s R&D pipeline and providing technical support for commercial radiopharmaceutical products. Prior to joining Nordion/BTG he was a project team leader at Merck, managing multidisciplinary teams that were responsible for the advancement of drug substance/product candidates from discovery to Phase II proof of concept studies. He holds a BS in Biochemistry (Memorial University of Newfoundland, 1995), a PhD, Bioanalytical Chemistry (Carleton University, 2000) and also completed a 2 year National Science and Engineering Research Council (NSERC) Post-Doctoral Fellowship at the University of Waterloo (Waterloo, Ontario) and Fraunhofer Institute for Toxicology/Experimental Medicine (Hannover, Germany). Dr. Mullett remains involved in the academic community as a previous Adjunct Professor at the University of Waterloo (Waterloo, Ontario) and is presently a member of the Editorial Advisory Board for Journal of Pharmaceutical and Biomedical Analysis. To date he has published over 35 peer review journal publications and holds 1 patent.


Tram Nguyen 

Tram Nguyen, partner, MH2 Technology Law Group


Panel: Regulatory, Patents and Intellectual Property Panel Discussion


Biography: Nguyen has experience in all aspects of patent law, including patent preparation, prosecution, client counseling and providing opinions. She has significant experience in medical devices and advising early stage and start-up companies. Prior to joining MH2, Nguyen founded Monument IP Law Group. Nguyen was formerly the director of IP and Legal Affairs for Paradigm Spine LLC and the vice president of IP at Musculoskeletal Clinical Regulatory Advisers. She is also a former associate and technical specialist with the law firms of Finnegan LLP and Nutter, McClennen & Fish LLP. Prior to becoming a registered patent attorney, Nguyen was a patent examiner at the U.S. Patent and Trademark Office, where she examined patent applications related to prosthetics and implants such as cardiac and vascular assist devices, stents, grafts, cardiac pumps, orthopedic and spinal implants, mammary and orthopedic prostheses, and related methods and surgical tools. She earned her Juris Doctor from George Mason University School of Law, her MS in biotechnology from The Johns Hopkins University and her BS in biology with minor in chemistry from George Mason University.


Greg Pomrink

Gregory J. Pomrink, vice president of research and development, NovaBone Products LLC


Panel: Dental Applications Panel Discussion


Biography: Pomrink is an experienced Vice President of Research and Development at NovaBone Products LLC., in an Alachua Florida. Gregory has an MS in Organic Chemistry from Lehigh University and an MBA from Eastern University along with over 25 yrs. of experience in medical device and industrial processing research and development. Mr. Pomrink has a well-rounded medical device background having held key positions at Stryker (Orthovita), Dentsply International and Integra LifeSciences focused on developing materials for dentistry, orthopedics/spine, and neurosurgery along with plastic and reconstructive surgery applications. He has a proven track record of success having been involved in the design, development and commercialization of several class III medical devices. Mr. Pomrink has extensive knowledge of design controls, program management, portfolio development, organic and analytical chemistry in conjunction with materials science and engineering. Gregory is a member of the American Chemical Society, Society for Biomaterials and the Orthopedic Research Society. Mr. Pomrink has 9 US Patents and 4 applications pending along with having filed 10 provisional applications within the last 2 years. In addition, he has more the 20 publications including journal articles, posters and abstracts.


Carolyn Primus

Carolyn Primus, consultant, Primus Consulting


Panel: Dental Applications Panel Discussion


Biography: Primus, PhD in Materials Science and Engineering, has worked in research and development for the government and private industry. For the last 25 years she has focused on materials for medical devices. She has been awarded 13 patents, 10 in dentistry. Her publications include more than a dozen articles in dental journals and chapters in two dental textbooks. Currently she is a consultant to medical device companies, a reviewer for 4 dental journals, and an adjunct Professor at LECOM in Bradenton, FL. She is also the PI for a SBIR II award and is commercializing her patent pending ideas for dental/medical cements at Avalon Biomed Inc.


Markus Reiterer

Markus Reiterer, senior principal scientist, Corp. Core Technologies, Medtronic, Inc.


Panel: Orthopedics I Panel Discussion


Biography: Reiterer received his Diplom-Ingeneur (MS) in materials science in 2000 and his PhD in mining in 2004 from Leoben. He conducted his graduate studies at the Fraunhofer-Institute for Mechanics of Materials in Freiburg, Germany, under direction of Prof. Hermann Riedel. During the next two years he continued his research in the field of computer simulation of powder compaction and sintering of ceramics as a postdoctoral appointee at Sandia National Labs. In 2006, he joined Medtronic and worked for 3 years in the research department of the Medtronic Energy and Component Center working mostly on mechanical design of batteries for implantable medical devices and durability of ceramic, electrical components. Since 2009, he has worked at the Corporate Core Technologies Department, where he currently leads the metals research group. Within Medtronic, he is recognized as expert for welding and joining, hydrogen embrittlement, finite element simulation, and failure analysis of complex systems. In 2013 he was appointed a Medtronic Technical Fellow.


Sunil Saini 

Sunil Saini, director, R&D, Integra Lifesciences


Panel: Orthopedics II Panel Discussion


Biography: Saini has over 12 years of experience in the medical device industry, specifically in the area of regenerative medicine. He currently leads a team of scientists and engineers in developing bone grafting products that encompass a broad spectrum of material technologies including synthetic, human and collagen. Saini received a B.S. degree in Chemical Engineering from the University of Maryland and a Ph.D. in Chemical Engineering from Georgia Tech.  


Aditya Sukthankar 

Aditya Sukthankar, regulatory consultant, mdi Consultants Inc.


Panel: Regulatory, Patents and Intellectual Property Panel Discussion


Biography: Sukthankar specializes in the preparation, review and submission of traditional and special 510(k) submissions, comprehensive label reviews of food, drugs and biologics. Previously he was customer relations executive at Wockhardt Pvt. Ltd. in India where he communicated with highly qualified nephrologists and oncologists about drug benefits to promote sales of the kidney products. Sukthankar earned his MS in regulatory affairs from Long Island University and his BS in pharmacy from Bharti Vidyapeeth College of Pharmacy. He is a member of member of Regulatory Affairs Professional Society of USA. 



Jacob Stiglich, Ultramet, Inc.


Panel: New Technologies Panel Discussion


Biography: Stiglich earned his BS in mechanical enginnering from Marquette University in 1961 and his PhD from Northwestern University in 1967. He has 15 years of experience working with companies on research/process development of metals and ceramic/metal composites and products. Stiglich has more than thirty five years experience in metallurgical technology, and is a recognized expert in ceramic composite fabrication, CVD fluidized-bed powder coating and ordnance materials. 

He is an independent consultant working with companies on research and process development for armor, cutting tools, biomedical applications, and wear/corrosion/high temperature resistant coatings.


Ben Tempel

Ben Tempel, CEO, NanOphthalmics


Panel: Clinical Testing Panel Discussion


Biography: Tempel is formally educated and skilled as an engineer and businessman with two engineering degrees from Georgia Tech and an MBA from Emory. He is an experienced entrepreneur having run his own commercial real estate development company. Tempel has spent his last few years gaining experience within the healthcare industry working for Sunrise Senior Living, the largest assisted living company in the country. His most recent experience has been working for Accredo Healthcare, the specialty pharmacy of Express Scripts, the largest PBM in the country with responsibilities for a portfolio of ten drugs within the pulmonary hypertension product line with P&L responsibility valued at $1.5B.


Zehra Tosun 

Zehra Tosun, ‎senior R&D biomedical engineer, NovaBone Products LLC


Panel: Orthopedics I Panel Discussion


Biography: Tosun has been the senior R&D biomedical engineer since 2012. After completing her BS in chemical engineering, she started her career as a research assistant in University of Oklahoma. In 2010, she relocated to University of Florida, and received her PhD in biomedical engineering in 2012. Her dissertation research focused on the use of ex vivo derived materials designed as implant scaffolds, and focusing on the events during regenerative processes to further detail the progressive changes. Currently at NovaBone, Tosun is responsible for designing and developing medical devices for regenerating bone and soft tissues. In addition, she has a diverse range of responsibilities including project management, IP development and planning and management of preclinical studies


George Wicks

George Wicks, president, Wicks Consulting Services


Panel: New Technologies Panel Discussion


Biography: Wicks is a consulting scientist recently retired from the Savannah River National Laboratory after 40 years, achieving the highest position in the organization’s technical ladder. He has more than 200 publications and 16 patents issued, to date, and has authored or co-authored 7 books and 9 invited chapters in texts and encyclopedias, and served as co-chairman for more than dozen international meetings on a variety of topics. He was also the technical lead working with the medical community on a new series of initiatives involving technologies developed within the nuclear field, which are now being tailored and evaluated for potential applications in diagnostics, repair/ replacement, and therapy/ treatment of a variety of medical conditions. Wicks currently works with the Applied Research Center  of South Carolina along with licensees of several of the inventions he as been associated with, in spinning out these technologies into the commercial sector.




Back to Top ↑